CVA
ACH

Ceredex Value Advisors’s Accendra Health ACH Stock Holding History

Ceredex Value Advisors’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-741,573
Closed -$32.6M – 156
2022
Q1 		$32.6M Sell
741,573
-528,400
-42% -$22.7M 0.39% 79
2021
Q4 		$55.2M Sell
1,269,973
-41,849
-3% -$1.64M 0.6% 66
2021
Q3 		$41M Buy
1,311,822
+767,522
+141% +$30.2M 0.46% 81
2021
Q2 		$23M Buy
+544,300
New +$21.2M 0.26% 94

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ceredex Value Advisors's ACH Position: Q2 2022 in Review

Ceredex Value Advisors sold out of Accendra Health (ACH) in Q2 2022, closing a stake of 741,573 shares — an estimated $32.6M sold.

Ceredex Value Advisors first reported a position in ACH in Q2 2021 and held it in 4 quarters. The position peaked at $55.2M in Q4 2021. 251 funds tracked by Wall St. Rank hold ACH as of Q2 2022.

  • Ceredex Value Advisors reported no remaining Accendra Health position as of Q2 2022 after selling out during the quarter.
  • Ceredex Value Advisors sold 741,573 Accendra Health shares in Q2 2022, an estimated $32.6M.
  • Ceredex Value Advisors first reported a position in Accendra Health in Q2 2021 and held it in 4 quarters.
  • Ceredex Value Advisors's Accendra Health position peaked at $55.2M in Q4 2021.
  • 251 funds tracked by Wall St. Rank held Accendra Health as of Q2 2022.

Based on Ceredex Value Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.